Simon James Harrison

41PUBLICATIONS

185CO-AUTHORS

Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (41)

Sort by Publication Date:

|May 30, 2026

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease.

|Apr 08, 2026

A phase 1/1b study of the BCMA-targeting bispecific T-cell engager pavurutamab for relapsed/refractory multiple myeloma.

Hans C Lee, Wouter J Plattel, Simon J Harrison

|Apr 06, 2026

Cytomegalovirus reactivation in patients with multiple myeloma receiving bispecific antibodies.

Enric Sastre-Escolà, Gemma K Reynolds, Michelle K Yong

|Feb 17, 2026

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Jan 15, 2026

The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy.

Arian Lasocki, Simon J Harrison, Michael Dickinson

|Dec 23, 2025

Establishing Barriers to and Enablers of Nurse-Enabled Subcutaneous Therapy Self-Administration Programs for Patients With Myeloma: Protocol for a Qualitative Descriptive Study.

Hayley Beer, Lisa Guccione, Amit Khot

Pageof 7

Frequent Collaborators

Benjamin W Teh

Andrew Spencer

Mark R Dowling

Paul A Beavis

Kevin Sek

Elizabeth Moore

Hang Quach

Phillip K Darcy

Phoebe J Ho

Michael Dickinson

Frequent Collaborators

Benjamin W Teh

Andrew Spencer

Mark R Dowling

Paul A Beavis